We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$178B
1-Year Est. Return
37.23%
This Fund
S&P 500
This Quarter
Est. Return
-1.67%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$100B
AUM Growth
-$8.74B
(-8%)
Cap. Flow
-$1.7B
Cap. Flow
% of AUM
-1.7%
Top 10 Holdings %
Top 10 Hldgs %
9.77%
Holding
2,893
New
146
Increased
1,494
Reduced
995
Closed
170
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MKS Inc
MKSI
|
+$219M |
| 2 |
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
|
+$185M |
| 3 |
Ross Stores
ROST
|
+$144M |
| 4 |
Progressive
PGR
|
+$134M |
| 5 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.49B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$762M |
| 3 |
Vanguard Total World Stock ETF
VT
|
+$476M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$348M |
| 5 |
Archer Daniels Midland
ADM
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.9% |
| 2 | Industrials | 13.89% |
| 3 | Financials | 12.91% |
| 4 | Consumer Discretionary | 10.69% |
| 5 | Healthcare | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Dave Inc
DAVE
$3.94B
| $109K | ﹤0.01% |
+839
| New | +$202K |
|
2477
Alignment Healthcare
ALHC
$2.86B
| $107K | ﹤0.01% |
11,124
+1,045
| +10% | +$9.41K |
|
2478
QuinStreet
QNST
$1.26B
| $107K | ﹤0.01% |
11,279
-12,775
| -53% | -$172K |
|
|
CYBE
2479
DELISTED
Cyberoptics Corp
CYBE
| $107K | ﹤0.01% |
2,646
+72
| +3% | +$2.77K |
|
2480
Vivid Seats
SEAT
$82.6M
| $106K | ﹤0.01% |
538
-16
| -3% | -$3.41K |
|
2481
Build-A-Bear
BBW
$467M
| $104K | ﹤0.01% |
5,707
+18
| +0.3% | +$340 |
|
2482
Hagerty
HGTY
$1.34B
| $103K | ﹤0.01% |
+10,845
| New | +$155K |
|
2483
MannKind Corp
MNKD
$1.26B
| $103K | ﹤0.01% |
33,048
-943
| -3% | -$3.44K |
|
2484
Radiant Logistics
RLGT
$390M
| $103K | ﹤0.01% |
16,211
+2,874
| +22% | +$19K |
|
|
MMAT
2485
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $101K | ﹤0.01% |
844
+57
| +7% | +$10.6K |
|
|
IIN
2486
DELISTED
IntriCon Corporation
IIN
| $101K | ﹤0.01% |
4,228
+210
| +5% | +$3.96K |
|
2487
Gevo
GEVO
$382M
| $100K | ﹤0.01% |
26,854
-43,570
| -62% | -$167K |
|
|
AMRS
2488
DELISTED
Amyris Inc.
AMRS
| $99K | ﹤0.01% |
28,773
-821
| -3% | -$3.68K |
|
2489
Cytek Biosciences
CTKB
$606M
| $98K | ﹤0.01% |
10,405
-295
| -3% | -$3.98K |
|
|
PNT
2490
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $98K | ﹤0.01% |
11,472
-328
| -3% | -$2.08K |
|
|
BELFB
2491
Bel Fuse Inc Class B
BELFB
$4.1B
| $97K | ﹤0.01% |
5,416
-538
| -9% | -$7.92K |
|
2492
Nature's Sunshine
NATR
$277M
| $97K | ﹤0.01% |
5,772
+370
| +7% | +$6.54K |
|
2493
Utah Medical Products
UTMD
$227M
| $97K | ﹤0.01% |
1,079
+49
| +5% | +$4.51K |
|
2494
Village Super Market
VLGEA
$616M
| $97K | ﹤0.01% |
3,971
-127
| -3% | -$2.93K |
|
|
CMBM
2495
DELISTED
Cambium Networks
CMBM
| $96K | ﹤0.01% |
4,044
-11,283
| -74% | -$273K |
|
|
AIV
2496
Aimco
AIV
$377M
| $95K | ﹤0.01% |
15,073
-4,637
| -24% | -$33K |
|
2497
Alico
ALCO
$290M
| $95K | ﹤0.01% |
2,517
+157
| +7% | +$5.46K |
|
2498
Douglas Elliman
DOUG
$166M
| $95K | ﹤0.01% |
16,530
-204,920
| -93% | -$1.55M |
|
2499
Sana Biotechnology
SANA
$1B
| $95K | ﹤0.01% |
12,553
-358
| -3% | -$2.9K |
|
|
HLGN
2500
DELISTED
Heliogen, Inc.
HLGN
| $95K | ﹤0.01% |
+704
| New | +$129K |
|
Similar funds
VGA
Victory Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Victory Capital Management held 2,893 positions worth $100B, down 8% from $109B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Victory Capital Management's Q1 2022 filing shows 146 new, 1,494 increased, 995 reduced and 170 closed positions. Its largest new stake was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.
- Victory Capital Management's largest Q1 2022 buy was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M.
- Victory Capital Management added most to MKS Inc in Q1 2022, an estimated $219M increase.
- Victory Capital Management's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.49B.
- Victory Capital Management fully exited Vanguard Total World Stock ETF in Q1 2022, selling an estimated $476M.
- Victory Capital Management's ten largest holdings make up 9.8% of its $100B portfolio in Q1 2022.
- Victory Capital Management opened 146 new positions and closed 170 in Q1 2022.
- Victory Capital Management's portfolio value fell 8% quarter-over-quarter to $100B.
Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.